Although perinatal depression has historically been underrepresented in biomarker research, emerging evidence suggests that certain markers, such as BDNF, neuroactive steroids, neuroimaging findings, and inflammatory markers, may hold translational relevance in this unique population. This evidence concerns the gene BDNF and perinatal asphyxia.